China Xinhuanet.com, June 7 (Chen Jing, Xiao Xin) The reporter was informed on the 7th that Shanghai University and Shanghai Cell Therapy Group signed a strategic cooperation agreement. The two parties will establish the "Mengchao Cancer Hospital Affiliated to Shanghai University" and the "Shanghai University Cell Therapy Innovation Research Institute" on the basis of Shanghai Mengchao Cancer Hospital, and strive to build an international first-class precision medical center, an international top cell therapy research center and a "immunotherapy + "A clinical research hospital featuring.
It is reported that Shanghai University is one of the first batch of high-level local colleges and universities in Shanghai to build a pilot university and an important training ground for talents. The Shanghai Cell Therapy Group was approved by the Shanghai Municipal Science and Technology Commission to build a closed loop of the entire cell industry chain through the integration of cell medicine, cell health and cell medicine. Shanghai Mengchao Cancer Hospital, a subsidiary of Shanghai Cell Therapy Group, is located in Shanghai's precision medicine and health service cluster. It is named after Professor Wu Mengchao, winner of the National Highest Science and Technology Award, a famous expert in hepatobiliary surgery, and an academician of the Chinese Academy of Sciences.
The strategic cooperation aims to achieve resource sharing and complementary advantages. Photo by Xiao Xin
The strategic cooperation aims to give full play to the abundant resources of the two parties in the field of cell therapy research and development, medical talent training and clinical medicine, to achieve resource sharing and complementary advantages. According to reports, the Mengchao Cancer Hospital affiliated to Shanghai University and the Cell Therapy Innovation Research Institute of Shanghai University were inaugurated on the same day, and a board of directors will be established to jointly explore affiliated hospitals that meet both "national and market conditions" and "innovate and make breakthroughs." The management mode of the affiliated research institute has continuously promoted the in-depth cooperation projects between the two parties.
The two sides will jointly explore a management model that conforms to both "national and market conditions" and "innovative and breakthrough". Photo by Xiao Xin
Three Nobel Prize winners from across the ocean sent congratulatory videos for the two parties to sign a strategic cooperation agreement. The 2013 Nobel Prize in Physiology or Medicine, Professor Randy Seckman of the University of California, Berkeley, said: Shanghai is located at the crossroads of Asia and the world, bringing together the best cultural knowledge and professionals from the East and the West to solve human Major issues. Professor Michel, the winner of the Nobel Prize in Chemistry in 1988 and director of the Max Planck Institute for Biochemistry in Germany, said that he believes that the two parties will work together to promote the integration of medicine and other disciplines, and promote Shanghai University to a higher level.
2019 Nobel Prize in Physiology or Medicine, Johns, USA. Greg of Hopkins University. Professor Simon said: The medical discipline of Shanghai University is concerned about the main diseases and health problems that threaten human health. The cooperation with Shanghai Cell Therapy Group at the Cell Therapy Innovation Research Institute will support its research and progress in the field of cell therapy for human health. Contribute to welfare. (Finish)